Fadanafil

DRUG2 trials

Sponsors

Sihuan Pharmaceutical Holdings Group Ltd.

Conditions

HealthyHealthy Subject

Phase 1

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects

CompletedNCT04312568

Sihuan Pharmaceutical Holdings Group Ltd.Healthy Subject

Start: 2018-08-10End: 2018-12-07Updated: 2020-03-18

Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects

CompletedNCT04467203

Sihuan Pharmaceutical Holdings Group Ltd.Healthy

Start: 2019-04-28End: 2019-06-28Updated: 2020-07-10